Skip to main content
. 2017 Jun 21;187(2):389–397. doi: 10.1093/aje/kwx251

Figure 2.

Figure 2.

Comparison of influenza vaccine effectiveness (VE) estimated using influenza (FLU)-negative controls (VEFLU−) with VE estimated using other/another respiratory virus (ORV)-positive controls (VEORV+) (A) and comparison of VE estimated using influenza-negative controls (VEFLU−) with VE estimated using panel (PAN)-negative controls (VEPAN−) (B) from all available VE estimates. Dotted lines represent the identity line. Ninety-five percent confidence intervals are shown in gray (point estimates and lower confidence limits below −110% are not shown).